Life sciences partner Michael Beauvais (Boston) analyzed the transactions climate in a 2019 JP Morgan Healthcare Conference preview article published Jan. 4 in Law360.
Mr. Beauvais explains that the life sciences industry is starting to shift in market mood, from bullish to cautionary. He predicts an increase in incremental deals, such as bolt-on acquisitions, as well as more carveout divestitures, where companies sell off non-core assets to other strategics as well as private equity.
Attorneys
Stay Up To Date with Ropes & Gray
Ropes & Gray attorneys provide timely analysis on legal developments, court decisions and changes in legislation and regulations.
Stay in the loop with all things Ropes & Gray, and find out more about our people, culture, initiatives and everything that’s happening.
We regularly notify our clients and contacts of significant legal developments, news, webinars and teleconferences that affect their industries.